Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

QR Code

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

Fabrizio Cantini, Carlotta Nannini, Laura NiccoliSecond Division of Medicine, Rheumatology Unit, Hospital of Prato, ItalyAbstract: Immunologic research has clarified many aspects of the pathogenesis of inflammatory rheumatic disorders. Biologic drugs acting on different steps of the immune response,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fabrizio Cantini, Carlotta Nannini, Laura Niccoli
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2009
Sujets:	Diseases of the musculoskeletal system RC925-935
Accès en ligne:	https://doaj.org/article/60de55b263df4f9e9a0ff39df114e8dc
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
par: Peter BB Jones, et autres
Publié: (2010)

Management of ankylosing spondylitis with infliximab
par: &Eacute;ric Toussirot, et autres
Publié: (2009)

Efficacy and safety of adalimumab in ankylosing spondylitis
par: Mounach A, et autres
Publié: (2014)

Optimal management of dactylitis in patients with psoriatic arthritis
par: Yamamoto T
Publié: (2015)

Rheumatoid arthritis: Disease or syndrome?
par: Jessica A Stanich, et autres
Publié: (2009)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
par: Montepaone M, et autres
Publié: (2014)

Serum heat-shock protein-65 antibody levels are elevated but not associated with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
par: Ulusoy H, et autres
Publié: (2018)

Genetics of rheumatoid arthritis: GWAS and beyond
par: McAllister KM, et autres
Publié: (2011)

Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009)

Certolizumab in the long-term treatment of rheumatoid arthritis
par: Scott DL, et autres
Publié: (2011)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
par: Curtis EM, et autres
Publié: (2014)

Rheumatoid arthritis-associated interstitial lung disease
par: Brown KK, et autres
Publié: (2012)

Long-term treatment of rheumatoid arthritis with adalimumab
par: Murdaca G, et autres
Publié: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
par: Michael G Feely
Publié: (2010)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
par: Yang M, et autres
Publié: (2012)

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
par: Joseph R Lutt
Publié: (2009)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
par: Augustine JM, et autres
Publié: (2012)

Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?
par: Mena Soory
Publié: (2010)

The use of administrative health care databases to identify patients with rheumatoid arthritis
par: Hanly JG, et autres
Publié: (2015)

The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases
par: Jeffrey R. Curtis, et autres
Publié: (2021)

Patients’ Perceptions of Person‐Centered Care in Early Rheumatoid Arthritis: A Qualitative Study
par: Ellen Landgren, et autres
Publié: (2021)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
par: Masahiko Mihara, et autres
Publié: (2011)

Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany
par: Wollenhaupt J, et autres
Publié: (2013)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
par: Takeo Isozaki, et autres
Publié: (2010)

The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016)

Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis
par: Takahashi R, et autres
Publié: (2014)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
par: Ulusoy H, et autres
Publié: (2020)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
par: Mysler E, et autres
Publié: (2021)

The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation
par: Townes SV, et autres
Publié: (2012)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
par: Michaël Doumen, et autres
Publié: (2021)

Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study
Publié: (2021)

Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis
par: Rabelo CF, et autres
Publié: (2018)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
par: Ríos C, et autres
Publié: (2017)

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
par: Michihito Sato, et autres
Publié: (2011)

Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
par: Gian Luca Erre, et autres
Publié: (2021)

The patient perspective: arthritis care provided by Advanced Clinician Practitioner in Arthritis Care program-trained clinicians
par: Warmington K, et autres
Publié: (2015)

Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
par: Almalag H, et autres
Publié: (2020)

Functional Disability and Its Determinants in Ecuadorian Patients with Rheumatoid Arthritis
par: Intriago M, et autres
Publié: (2020)

Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives
par: Tahir H, et autres
Publié: (2020)

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
par: Roy Fleischmann
Publié: (2009)